Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azeliragon with Dexamethasone for Post-Resection Cerebral Edema in Glioblastoma
NCT05773664Phase 1Withdrawn
- Sponsor
- City of Hope
- Start
- Nov 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of azeliragon in cerebral edema (2 arms), sponsored by City of Hope. Primary endpoints: Lack of feasibility and Incidence of adverse events. Planned start Nov 2024; status: withdrawn.
02
Drugs
azeliragon
03
Conditions
cerebral edema
Beyond the preview
Go deeper on NCT05773664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05773664.